Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6710202 | 7380711 | I | 6710202-7 | 20100401 | 20100416 | 20100430 | EXP | TCI2010A01499 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | YR | M | N | 20100429 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6710202 | 1013623250 | PS | BASEN (VOGLIBOSE) | 2 | ORAL | 15 MG (15 MG, 1-2), PER ORAL | D | 21073 | |||
| 6710202 | 1013647018 | SS | ACTOS | 1 | ORAL | PER ORAL | |||||
| 6710202 | 1013647020 | SS | AMARYL | 1 | ORAL | 3 MG (3 MG, 1 D), PER ORAL | |||||
| 6710202 | 1013647022 | SS | GLACTIV (SITAGLIPTIN PHOSPHATE HYDRATE) (ORAL ANTIDIABETICS) | 2 | ORAL | PER ORAL |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6710202 | 1013623250 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6710202 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6710202 | HYPOGLYCAEMIC COMA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6710202 | FGN |
| 6710202 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6710202 | 1013623250 | 20100413 |